HF
MBIO icon

HRT Financial’s Mustang Bio MBIO Stock Holding History

HRT Financial’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,098
Closed -$9K – 3028
2024
Q4 		$9K Buy
+1,098
New +$12.1K ﹤0.01% 2292
2023
Q2 		– Sell
-21
Closed -$5K – 2928
2023
Q1 		$5K Buy
21
+7
+50% +$2.87K ﹤0.01% 2289
2022
Q4 		$4K Sell
14
-3
-18% -$1.02K ﹤0.01% 2290
2022
Q3 		$5K Buy
17
+2
+13% +$927 ﹤0.01% 2591
2022
Q2 		$6K Buy
+15
New +$8.3K ﹤0.01% 2726
2021
Q1 		– Sell
-20
Closed -$57K – 2959
2020
Q4 		$57K Buy
+20
New +$47.8K ﹤0.01% 1688

Other funds holding MBIO

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HRT Financial's MBIO Position: Q1 2025 in Review

HRT Financial sold out of Mustang Bio (MBIO) in Q1 2025, closing a stake of 1,098 shares — an estimated $9K sold.

HRT Financial first reported a position in MBIO in Q4 2020 and held it in 6 quarters. The position peaked at $57K in Q4 2020. 16 funds tracked by Wall St. Rank hold MBIO as of Q1 2025.

  • HRT Financial reported no remaining Mustang Bio position as of Q1 2025 after selling out during the quarter.
  • HRT Financial sold 1,098 Mustang Bio shares in Q1 2025, an estimated $9K.
  • HRT Financial first reported a position in Mustang Bio in Q4 2020 and held it in 6 quarters.
  • HRT Financial's Mustang Bio position peaked at $57K in Q4 2020.
  • 16 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2025.

Based on HRT Financial's 13F filing for Q1 2025, filed 15 May 2025.